Supernus Announces Fourth Quarter and Full Year 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Supernus Pharma (SUPN) Misses Q4 EPS by 25c
February 28, 2023 4:15 PM ESTSupernus Pharma (NASDAQ: SUPN) reported Q4 EPS of $0.43, $0.25 worse than the analyst estimate of $0.68. Revenue for the quarter came in at $167.33 million versus the consensus estimate of $180.38 million.
For earnings history and earnings-related data on Supernus Pharma (SUPN) click here.
... More